9th World Drug Manufacturing (WDM 2010)

Increasing innovation and reducing costs across global operations.

World Drug Manufacturing 2010 will debate the latest industry challenges occurring throughout small molecule and biologic manufacturing. The industry is facing increasing pressure to reduce costs, in order to remain competitive against generics. It is therefore more important than ever that companies reduce waste, streamline processes and increase their global presence.

The programme for World Drug Manufacturing 2010 is well underway with leading speakers lined up from Novartis, Pfizer, Merck Sharp and Dohme and NIPTE dealing with issues such as:

Cost reduction through sustainable manufacturing strategies Implementing next generation continuous manufacturing technologies Developing a streamlined and consistent global supply network Combining lean and Quality by Design Balancing compliance and cost Managing technology transfer across sites and organisations Identifying and engaging global suppliers and CMO s Influencing COGS throughout the product development and manufacturing lifecycle If there are any themes you would like to see covered in addition to the above or would like to join our panel to help develop the programme to ensure it truly reflects the needs of the industry, please contact us on +44 (0)207 202 7690